Emami Ltd (EMAMILTD) Q3FY26 Concall Summary - Dec-2025 Qtr
Performance Overview
- The company reported a strong, broad-based performance for the quarter, fully aligned with its strategic priorities and expectations, showing sequential improvement following earlier GST disruptions.
- Growth was driven by a favorable winter season, which led to stronger offtake across the winter portfolio and healthcare range, alongside a robust domestic volume growth of 9%.
- Strategic subsidiaries, The Man Company and Brillare, collectively delivered a robust growth of 31%, highlighting the success of the company's focus on new-age brands.
- The company's Omni-channel strategy continues to yield positive results, with Quick Commerce doubling its sales and organized channels now contributing 32% to year-to-date sales, an increase of 280 basis points over the previous year.
- Gross margins expanded due to rigorous cost discipline, judicious price hikes, and stable input prices, reflecting strong operational management and financial health.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.